ARTICLE | Clinical News
Diacol: Phase III
May 3, 1999 7:00 AM UTC
InKine Pharmaceutical Co. Inc. (INKP), Blue Bell, Penn. Product: Diacol Business: Metabolic Therapeutic category: Adjunct Target: Intestinal epithelial cells Description: Sodium phosphate gastrointes...